Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Surgical acquires vascular repair technology:

This article was originally published in Clinica

Executive Summary

US Surgical and EndoTex Interventional Systems have agreed to collaborate on the development of vascular repair technologies for aortic aneurysms and AV fistulas. The companies plan to begin clinical trials of EndoTex' stent graft for abdominal aortic aneurysm repair later this year. The agreement gives US Surgical the right to acquire the stent grafts and delivery systems, which can be used for iliac, femoral and thoracic aneurysm repair. Around 300,000 patients suffer an aneurysm every year in the US but only a small percentage of cases can be treated surgically.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT083958

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel